Dergiler / Kulak Burun Boğaz Uygulamaları / 2021 / Cilt: 9 - Sayı: 1

How does allergen-specific immunotherapy affect mean platelet volume and complete blood inflammation markers?

Alerjen spesifik immünoterapi ortalama trombosit hacmini ve tam kan inflamasyon belirteçlerini nasıl etkiler?

Sayfa
1–7
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Based on these results, it can be concluded that not only local inf lammation, but also systemic inf lammation contribute to the pathogenesis of AR, and not only local inf lammation, but also systemic inf lammation can be suppressed with ASI.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: This study aims to investigate how allergen-specific immunotherapy (ASI) affected mean platelet volume (MPV), platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), eosinophil-to-lymphocyte ratio (ELR), basophil-to-lymphocyte ratio (BLR), and lymphocyte-to-monocyte ratio (LMR), which are essential indicators of systemic inf lammation.
📊
Temel Bulgular & Veri:Patients and Methods: Medical records of a total of 19 patients (7 males, 12 females; mean age: 33 years; range, 18 to 45 years) who received ASI for medical treatment-resistant seasonal or perennial allergic rhinitis (AR) and 24 healthy individuals (12 males, 12 females; mean age: 34 years; range, 18 to 45 years) were retrospectively analyzed between January 2015 and January 2020.
💡
Sonuç & Katkı:Conclusion: Based on these results, it can be concluded that not only local inf lammation, but also systemic inf lammation contribute to the pathogenesis of AR, and not only local inf lammation, but also systemic inf lammation can be suppressed with ASI.
🔬Tür:Araştırma Makalesi
📍Kapsam:2015 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: This study aims to investigate how allergen-specific immunotherapy (ASI) affected mean platelet volume (MPV), platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), eosinophil-to-lymphocyte ratio (ELR), basophil-to-lymphocyte ratio (BLR), and lymphocyte-to-monocyte ratio (LMR), which are essential indicators of systemic inf lammation. Patients and Methods: Medical records of a total of 19 patients (7 males, 12 females; mean age: 33 years; range, 18 to 45 years) who received ASI for medical treatment-resistant seasonal or perennial allergic rhinitis (AR) and 24 healthy individuals (12 males, 12 females; mean age: 34 years; range, 18 to 45 years) were retrospectively analyzed between January 2015 and January 2020. The patients were divided into three groups as follows: control group including healthy individuals (Group 1, n=24); pre-immunotherapy (PreIT) treatment (Group 2, n=19); and post-immunotherapy (PostIT) treatment group (Group 3, n=19). The prespecified markers were calculated from the routine complete blood count analyses and the results were compared among the PreIT, PostIT, and control groups. Results: The MPV after ASI significantly increased in the PostIT group, compared to the PreIT group (p 0.05). Basophil and BLR values of the PostIT group significantly decreased, compared to the PreIT group (p<0.05). Conclusion: Based on these results, it can be concluded that not only local inf lammation, but also systemic inf lammation contribute to the pathogenesis of AR, and not only local inf lammation, but also systemic inf lammation can be suppressed with ASI.

Abstract

Amaç: Bu çalışmada alerjen spesifik immünoterapinin (SİT) sistemik inf lamasyonun temel göstergeleri olan ortalama trombosit hacmi (MPV), trombosit-lenfosit oranı (PLR), nötrofil-lenfosit oranı (NLR), eozinofil-lenfosit oranı (ELR), bazofil-lenfosit oranı (BLR) ve lenfosit-monosit oranını (LMR) ne yönde etkilediği araştırıldı. Hastalar ve Yöntemler: Ocak 2015 - Ocak 2020 tarihleri arasında medikal tedaviye dirençli mevsimsel veya yıl boyu devam eden alerjik rinit (AR) nedeniyle SİT uygulanan toplam 19 hasta (7 erkek, 12 kadın; ort. yaş: 33 yıl; dağılım, 18-45 yıl) ile 24 sağlıklı bireyin (12 erkek, 12 kadın; ort. yaş: 34 yıl; dağılım, 18-45 yıl) tıbbi kayıtları retrospektif olarak incelendi. Hastalar şu şekilde üç gruba ayrıldı: sağlıklı bireylerden oluşan kontrol grubu (Grup 1, n=24), immünoterapi öncesi (PreIT) grup (Grup 2, n=19) ve immünoterapi sonrası (PostIT) grup (Grup 3, n=19). Önceden belirlenen belirteçler, rutin tam kan sayımı analizlerinden hesaplandı ve sonuçlar PreIT, PostIT ve kontrol grupları arasında karşılaştırıldı. Bulgular: PreIT grubuna kıyasla, PostIT grubunda SİT sonrası MPV anlamlı düzeyde arttı (p 0.05). PostIT grubunun bazofil ve BLR değerleri, PreIT grubuna kıyasla anlamlı düzeyde azaldı (p<0.05). Sonuç: Bu sonuçlara göre, yalnızca lokal inf lamasyonun değil, aynı zamanda sistemik inf lamasyonun da AR patogenezine katkıda bulunduğu ve yalnızca lokal inf lamasyonun değil, sistemik inf lamasyonun da SİT ile baskılanabileceği sonucuna varılabilir.

🔖

Bu Makaleye Atıf Yap

ÇINAR, Z., YİĞİT, Ö., SERVER, E. A., ERDENEN, F. (2021). How does allergen-specific immunotherapy affect mean platelet volume and complete blood inflammation markers?. Kulak Burun Boğaz Uygulamaları, Cilt: 9 - Sayı: 1, 1–7. https://ajindex.com/articles/274515

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Kakli HA, Riley TD. Allergic rhinitis. Prim Care 2016;43:465-75
  2. Walker SM, Durham SR, Till SJ, Roberts G, Corrigan CJ, Leech SC, et al. Immunotherapy for allergic rhinitis. Clin Exp Allergy 2011;41:1177-200
  3. Göker AE, Ekincioglu E, Alagöz MH, Hummatov R, Arkan ME, Baskadem Yilmazer A, et al. The association of allergic rhinitis severity with neutrophil-lymphocyte and platelet-lymphocyte ratio in adults. Eur Arch Otorhinolaryngol 2019;276:3383-8
  4. Şahin E, Bafaqeeh SA, Güven SG, Çetinkaya EA, Muluk NB, Coşkun ZO, et al. Mechanism of action of allergen immunotherapy. Am J Rhinol Allergy 2016;30:1-3
  5. Zhang W, Lin C, Sampath V, Nadeau K. Impact of allergen immunotherapy in allergic asthma. Immunotherapy 2018;10:579-93
  6. Wang W, Yin J. Is it worthy to take full-course immunotherapy for allergic rhinitis? About efficacy biomarker of allergen immunotherapy. Scand J Immunol 2020;91:e12817
  7. Håkansson L, Heinrich C, Rak S, Venge P. Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: effect of immunotherapy. J Allergy Clin Immunol 1997;99:551-62
  8. Korniluk A, Koper-Lenkiewicz OM, Kamińska J, Kemona H, Dymicka-Piekarska V. Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inf lammatory Conditions. Mediators Inflamm 2019;2019:9213074
  9. Larmann J, Handke J, Scholz AS, Dehne S, Arens C, Gillmann HJ, et al. Preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with major adverse cardiovascular and cerebrovascular events in coronary heart disease patients undergoing non-cardiac surgery. BMC Cardiovasc Disord 2020;20:230
  10. Bojaxhiu B, Templeton AJ, Elicin O, Shelan M, Zaugg K, Walser M, et al. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation. Radiat Oncol 2018;13:216
  11. Yenigun A, Sezen S, Calim OF, Ozturan O. Evaluation of the eosinophil-to-lymphocyte ratio in pediatric patients with allergic rhinitis. Am J Rhinol Allergy 2016;30:e21-5
  12. Çekici Y, Yılmaz M, Seçen Ö. New inf lammatory indicators: association of high eosinophil-to-lymphocyte ratio and low lymphocyte-to-monocyte ratio with smoking. J Int Med Res 2019;47:4292-303
  13. Brescia G, Pedruzzi B, Barion U, Cinetto F, Giacomelli L, Martini A, et al. Are neutrophil-, eosinophil-, and basophil-to-lymphocyte ratios useful markers for pinpointing patients at higher risk of recurr